Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP905868.RAXT3YJY-uGG6A1LOFr5vekyK7yPtszkwlPy9Lqagsl3E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP905868.RAXT3YJY-uGG6A1LOFr5vekyK7yPtszkwlPy9Lqagsl3E130_assertion type Assertion NP905868.RAXT3YJY-uGG6A1LOFr5vekyK7yPtszkwlPy9Lqagsl3E130_head.
- NP905868.RAXT3YJY-uGG6A1LOFr5vekyK7yPtszkwlPy9Lqagsl3E130_assertion description "[In the pilot testing group, CST6 promoter was methylated in 8/27 (29.6%) operable breast cancer patients, in 6/46 (13.0%) patients with verified metastasis but none of 37 healthy individuals (0%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905868.RAXT3YJY-uGG6A1LOFr5vekyK7yPtszkwlPy9Lqagsl3E130_provenance.
- NP905868.RAXT3YJY-uGG6A1LOFr5vekyK7yPtszkwlPy9Lqagsl3E130_assertion evidence source_evidence_literature NP905868.RAXT3YJY-uGG6A1LOFr5vekyK7yPtszkwlPy9Lqagsl3E130_provenance.
- NP905868.RAXT3YJY-uGG6A1LOFr5vekyK7yPtszkwlPy9Lqagsl3E130_assertion SIO_000772 23006792 NP905868.RAXT3YJY-uGG6A1LOFr5vekyK7yPtszkwlPy9Lqagsl3E130_provenance.
- NP905868.RAXT3YJY-uGG6A1LOFr5vekyK7yPtszkwlPy9Lqagsl3E130_assertion wasDerivedFrom befree-20140225 NP905868.RAXT3YJY-uGG6A1LOFr5vekyK7yPtszkwlPy9Lqagsl3E130_provenance.
- NP905868.RAXT3YJY-uGG6A1LOFr5vekyK7yPtszkwlPy9Lqagsl3E130_assertion wasGeneratedBy ECO_0000203 NP905868.RAXT3YJY-uGG6A1LOFr5vekyK7yPtszkwlPy9Lqagsl3E130_provenance.